POSTED October 4, 2017 07:00 AM Eastern Standard Time

ALAMEDA, Calif. – (BUSINESS WIRE) – AllCells, LLC, a leading provider of hematologic primary cell products for global life science research and further manufacturing of allogeneic cell therapy products is pleased to announce the successful deployment of its new Oracle enterprise resource planning (ERP) system, effective October 2.

The company spent the past twelve months identifying opportunities to significantly improve business processes, selecting an appropriate ERP system to meet future growth needs, and training staff. The new ERP system fully integrates these new business processes to streamline manufacturing operations from order generation to product delivery.

“The new ERP solution is expected to have a dramatic, positive impact on the productivity of our business which directly benefits customers and employees in many ways”, said Jay Tong, M.D, the company’s President/CEO. “For example, the ERP system nicely integrates with our newly designed, proprietary donor management system (DMS) to increase speed and accuracy of identifying and scheduling active qualified donors for cell collections at our LeukoLab donor centers located in Quincy, MA and Alameda, CA. We expect to substantially improve inventory management of hundreds of cryopreserved products with customers and global distributors having visibility into real-time inventory. Moreover, the cloud-based system strengthens the security and preservation of customer data for business continuity purposes, and real-time inventory information enables our teams to generate quotes more quickly for our customers.”


About AllCells, LLC

AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies.  Leveraging its expertise in hematopoietic and immune cell isolation and characterization together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™) custom designed according to customer criteria.  For more information, please visit


MEDIA Contact:

Wayne E. Vaz, VP, Corporate Development

AllCells, LLC, P (510) 671-8676

See official Business Wire release: here.